All Diffusion Optics Technology Articles
-
788ClinicalHow Safe and Effective Are Next-Generation Spectacle Lenses for Myopia Management?
March 1, 2024 By Nabin Paudel, BOptom, PhD Myopia is a growing public health concern that will affect an estimated 4.7 billion...
-
558Latest Myopia NewsSightGlass’ DOT Spectacle Lenses Receive FDA Breakthrough Device Designation
February 14, 2024 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses have received Breakthrough Device designation from the...
-
364Latest Myopia NewsDebbie Jones, Jill Woods Discuss SightGlass Vision’s DOT Spectacles at THE Myopia Meeting
January 15, 2024 TORONTO – At THE Myopia Meeting held here Sunday, December 3, 2023, Debbie Jones, BSc(Hons), FCOptom, FAAO, and Jill...
-
1.3KClinicalThe Impact of Two Spectacle Myopia Control Designs on Identical Twins
sponsored content December 15, 2023 By Tina Goodhew, OD, with commentary by Cristina Schnider OD, MBA, FAAO Though not yet available in...
-
962Latest Myopia NewsIMI Shares Updated 2023 Myopia Facts and Figures Infographic
November 9, 2023 SYDNEY, Australia — The International Myopia Institute (IMI) has released its 2023 update for the Facts and Finding Infographic....
-
952Latest Myopia NewsSightGlass Shares Positive Results at American Academy of Optometry 2023
October 16,2023 NEW ORLEANS, La. — At the American Academy of Optometry’s 2023 Annual Meeting, SightGlass Vision shared three studies that further...
-
1.2KClinicalNext-Gen Spectacle Designs for Myopia Management: What We Know Now
October 2, 2023 By Nabin Paudel, BOptom, PhD Myopia management using optical interventions, particularly spectacle lenses, has evolved over the past few...
-
650Latest Myopia NewsSightGlass Vision Releases First White Paper on DOT Lenses
September 20, 2023 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses are the subject of a recently released...
-
666Latest Myopia NewsSightGlass Presents Four-Year Results of CYPRESS Trial at CCOS
September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...
-
941Latest Myopia NewsSightGlass Vision’s DOT Spectacles Found to be Effective for Reducing Myopia Progression
October 25, 2022 LOS ALTOS, Calif. — New findings from SightGlass Vision’s three-year CYPRESS clinical trial have highlighted the efficacy of the...
-
1.6KLatest Myopia NewsThe International Myopia Conference Breaks All Records
September 12, 2022 ROTTERDAM, The Netherlands — After a three-year hiatus, the International Myopia Conference returned with its best attended event since...
-
1.4KLatest Myopia NewsSightGlass Vision Spectacles Slow Myopia Progression for 6- and 7-Year-Olds
June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...
-
1.9KClinicalReview of Myopia Management Spectacles: MiYOSMART, Stellest, and SightGlass
June 1, 2022 By Dean Psarakis, B.Optom, Senior Research Optometrist, Brien Holden Vision Institute Novel spectacle designs comprising D.I.M.S., H.A.L.T., and D.O.T....
-
7.7KClinicalECPs Share Real-World Experience with DOT Spectacle Lenses
sponsored content June 1, 2022 One of few spectacle lenses available to slow the progression of myopia, SightGlass Vision’s novel Diffusion Optics...
-
1.5KLatest Myopia NewsSightGlass Vision Announces New Executive Team
March 24, 2022 PALO ALTO, Calif. — SightGlass Vision announced the appointment of three new leadership positions to its executive team. Andrew...
-
3.6KClinicalExperiencing SightGlass Vision’s Spectacle Lenses
December 15, 2021 By Joe Rappon, OD, MS, FAAO, and Kylvin Ho, OD, FIAOMC As children continue to develop myopia at earlier...